View
comments
Pfizer-BioNTech are planning to ask the U.S. Food and Drug Administration (FDA) to authorize their COVID-19 vaccine for all Americans aged 18 and older.
Three unnamed White House officials told The Washington Post that the submission could come as early as this week
Currently, booster of Pfizer's vaccine are only authorized for those aged 65 and older or at high risk due to their jobs or underlying conditions more than six months after the first graphs.
But the extension would complete the Biden administration's goal for all adults announced over the summer.
A Pfizer spokesman Kit Longley declined to confirm the firm's plans to the Post.
Pfizer-BioNTech are planning to ask the FDA to authorize their COVID-19 vaccine for all Americans aged 18 and older. Pictured: Nicole Fahey, of Altadena, six months pregnant, receives a Pfizer vaccine booster shot in Los Angeles, California, November 2021
Third doses are currently only authorized for those aged 65 and older and at high risk due to their jobs or underlying conditions. Pictured: A healthcare worker administers a third dose of the Pfizer vaccine at a senior living facility in Worcester, Pennsylvania, August 2021
In August, boosters were approved for immunocompromised Americans who had received either the Pfizer or Moderna vaccine after data showed they were less likely to develop high antibody levels after two doses.
Shortly after, the White House announced
